This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Member Connect   Tech Transfer   Events   Publications   Marketplace Oct. 21, 2010
 
 
 

Boosting technology transfer in the Philippines
Manila Bulletin    Share   Share on FacebookTwitterShare on LinkedinE-mail
article
The Philippines, Technology Transfer Act, which was signed into law on March 23, and took effect on May 8, grants intellectual property ownership to research and development institutions that performed the research and development using public funds. The law paves the way for scientists to benefit from the results of public-funded research. It allows scientists, state universities and colleges, and research institutions to profit from research funded by taxpayers through the commercialization of research outputs, through the creation of a spin-off company or through licensing, or the sale of the technology and/or intellectual property rights. More



Judge rules kinetic concepts' patents invalid
The Wall Street Journal (subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Kinetic Concepts Inc.'s shares slumped after a judge rendered invalid two key patents the medical-technology company has used to defend its wound-therapy franchise. The ruling by the U.S. District Court for the Western District of Texas effectively overturns a jury verdict from March that found U.K.-based medical-device maker Smith & Nephew PLC had infringed the patents. That case involved Smith & Nephew's Renasys products and two patents owned by Wake Forest University in Texas and licensed to Kinetic and included damages of $1.2 million. Kinetic said it will continue to analyze the court's ruling and assess its next steps, including an appeal. More

Enterprise Fellowship scheme helps tech startups to thrive
Business7    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scottish businesses partnering with universities on the development of new technologies are being urged to apply to the Enterprise Fellowship program. The scheme is still only seeing a handful of applications from outside academia even though guidelines were relaxed three years ago. Gavin Laird, who heads up the program, said: "We opened up the scheme to ideas from companies partnering with universities bringing either their own intellectual property in or bringing intellectual property in from somewhere else." More

MultiCell Technologies Inc. subsidiary inks worldwide licensing
for medical devices IP

International Business Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
MultiCell Technologies Inc. and its majority owned subsidiary Xenogenics Corp. jointly announced Xenogenics' acquisition of Ideal™ BioStent, as well as Xenogenics' worldwide exclusive license deal with Rutgers University for rights to certain intellectual property related to the Ideal BioStent. Analysts forecast the multi-billion dollar interventional cardiology and intravascular stent market to reach $4.6 billion at a growth rate of 3 percent to 4 percent annually. Advances in the market center on medical devices innovation that address long-term safety concerns, including the improvement of blood vessel health. The Ideal BioStent's is a layered technology that integrates different combinations of polymers and drugs to enable the optimization of the delivery of combination drug therapies to provide superior clinical results. More



Intricate, curving 3-D nanostructures created using capillary
action forces

Nanowerk News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Twisting spires, concentric rings, and gracefully bending petals are a few of the new 3-D shapes that the University of Michigan engineers can make from carbon nanotubes using a new manufacturing process. The process is called "capillary forming," and it takes advantage of capillary action, the phenomenon at work when liquids seem to defy gravity and travel up a drinking straw of their own accord. The university is pursuing patent protection for the intellectual property, and is seeking commercialization partners to help bring the technology to market. More

Research partnership between universities helps spur growth
for Michigan's economy

The State News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The University Research Corridor — comprised of MSU, the University of Michigan and Wayne State University — contributes to Michigan's ability to foster job creation, retain graduates and spur competition among other national and worldwide research "clusters," said Jeff Mason, executive director of the URC. The URC is Michigan's top research and academia alliance formed to positively benefit the state. The universities share faculty and research projects, and out of that comes growth. Research topics range from Great Lakes climate studies to stem cells. In the 2010 Empowering Michigan report, the net economic impact to the state of the alliance reached about $14.8 billion — an increase of about 15 percent to $12.9 billion in 2006. More

Safeguard your research mouse models

The Jackson Laboratory manages thousands of mouse models for the worldwide biomedical research community. Many are accepted by our repository at no cost and donor institutions may reserve commercial use rights. Learn more


UM System to invest $5 million in university-affiliated entrepreneurs
The Columbia Missourian    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The University of Missouri System Enterprise Investment program, which is now open for applications, will invest up to $5 million in university-affiliated startups. Chosen entrepreneurs will receive up to a $500,000 seed to help cultivate their new businesses. The UM System will draw from its portfolio of investments, worth $2.4 billion as of fiscal year 2009, to fund the program. The purpose is to promote the growth of university-based intellectual property, said Mike Nichols, vice president for research and economic development. More

UniQuest to show off new projects at AusBiotech
Australian Life Scientist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
UniQuest, the commercialization arm of the University of Queensland in Australia will be showing off a host of new innovations and projects, including a cell-based therapy to combat infections in cancer patients undergoing chemotherapy. Neutropenia is a high-risk blood disorder that occurs when chemotherapy destroys the white blood cells needed to defend the body from bacterial and fungal infections. University of Queensland researchers at the Australian Institute for Bioengineering and Nanotechnology have developed TheraPhil to combat neutropenia, with the technology ready to begin phase I clinical trials, which is where a commercial partner is needed. More
 


The Rumor Mill

What are people saying about Hopes Creek? See the testimonials yourself. MORE

 
AUTM Newsbrief
Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Hailey Sasser, Content Editor, 469.420.2630

Contribute news
This edition of the AUTM Newsbrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Oct. 14, 2010
Oct. 7, 2010
Sep. 30, 2010
Sep. 23, 2010



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063